Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2012
06/28/2012US20120165264 Degradation-Stabilised, Biocompatible Collagen Matrices
06/28/2012US20120164199 Chemically and/or biologically reactive compounds
06/28/2012US20120164195 Cosmetic Films
06/28/2012US20120164184 DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
06/28/2012US20120164099 Use of human prostate cell lines in cancer treatment
06/28/2012US20120164094 Production Method Of High-Viscosity O/W Cream
06/28/2012US20120164083 Sweetness Enhancers Including Rebaudioside A or D
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164069 Compositions and methods for surface abrasion with frozen particles
06/28/2012CA2822591A1 Materials and methods for conjugating a water soluble fatty acid derivative to a protein
06/28/2012CA2822583A1 Use of aniline in the radiostabilization of oxime ligation reactions
06/28/2012CA2822359A1 Enhanced immune response in bovine species
06/28/2012CA2822227A1 Fluid compositions comprising a structuring agent
06/28/2012CA2822208A1 Triggered polymer viscous pill and methods of using the same
06/28/2012CA2822088A1 Pharmaceutical composition containing active plant substances
06/28/2012CA2821659A1 Solid retard formulations based on solid dispersions
06/28/2012CA2821382A1 Phosphomycin pharmaceutical composition
06/28/2012CA2821230A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012CA2819269A1 Anti-mesothelin antibodies and immunoconjugates
06/28/2012CA2818691A1 Methods and compositions for wound treatment
06/28/2012CA2817524A1 Pharmaceutical formulations containing corticosteroids for topical administration
06/27/2012EP2469285A1 Water soluble metal and semiconductor nanoparticle complexes
06/27/2012EP2468765A1 Multimer of extracellular domain of cell surface functional molecule
06/27/2012EP2468760A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide
06/27/2012EP2468304A2 Process for preparing stable drug conjugates
06/27/2012EP2468303A1 Functionalized nucleic acids and particles comprising them for the treatment of HIV infections
06/27/2012EP2468293A1 Use of pegylated il-10 to treat cancer
06/27/2012EP2468284A1 Method of improving immune function in mammals using Lactobacillus strains with certain lipids
06/27/2012EP2468281A1 Quinoline derivative-containing pharmaceutical composition
06/27/2012EP2468260A2 Liposomes covered with the extracellular domain of the apo2l/trail protein
06/27/2012EP2468259A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/27/2012EP2467465A1 Alcoholic compositions having a lowered risk of acetaldehydemia
06/27/2012EP2467375A1 Forms of dexlansoprazole and processes for the preparation thereof
06/27/2012EP2467170A1 Vesicular formulations
06/27/2012EP2467166A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders
06/27/2012EP2467165A2 Targeted immunoconjugates
06/27/2012EP2467154A2 Tumoricidal, bactericidal, or viricidal macrophage activation
06/27/2012EP2467131A2 Controlled-release formulations of anabaseine compounds and uses thereof
06/27/2012EP2467130A2 Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
06/27/2012EP2467129A1 The granules with improved solubility and stability
06/27/2012EP2467127A1 Topical gels
06/27/2012EP2467029A1 Tabletting of erythritol and isomalt
06/27/2012EP2297172B1 Process for producing nanoparticles
06/27/2012EP2120873B1 Topical dosage form comprising tri-substituted glycerol compounds
06/27/2012EP2062581B1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents
06/27/2012EP2061505B1 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells
06/27/2012EP1968644B1 Polymer conjugates of glp-1
06/27/2012EP1743041B1 Modified viral vector particles
06/27/2012EP1722834B1 Matrix comprising naturally-occurring crosslinked protein backbone
06/27/2012EP1670449B1 Thyroid hormone analogs and methods of use in angiogenesis
06/27/2012CN1903243B Guhong control-release tablets and prepn. method therefor
06/27/2012CN1895223B Production method of elaioplast
06/27/2012CN1893930B G i tract delivery systems
06/27/2012CN1891299B Sugar alcohol composition for tableting
06/27/2012CN1879887B Insoluble drug delivery system based on water-soluble cyclodextrin
06/27/2012CN1812773B Polyethylene oxide-based films and drug delivery systems made therefrom
06/27/2012CN102516777A Aqueous solution of silk fibroin and preparation method for aqueous solution
06/27/2012CN102516739A Multiple sensitive hydrogel material and preparation method thereof
06/27/2012CN102516696A Method for preparing bioluminescent nano thermometer
06/27/2012CN102516604A Method for preparing lactose-starch complex
06/27/2012CN102516566A Method for preparing biodegradable polymer nano particles
06/27/2012CN102516564A Soap-free preparation method for biodegradable polymer nano particles
06/27/2012CN102516552A Degradable acid-sensitive macromolecular amphipathic cationic block copolymers and micellar particles and preparation method thereof
06/27/2012CN102516533A Block copolymer for drug conjugates and their pharmaceutical compositions
06/27/2012CN102516480A Preparation method of polyamine-type amphipathic block polyelectrolyte
06/27/2012CN102516428A Method for preparing initiator for polyamine amphipathic block polyelectrolyte
06/27/2012CN102516417A Cyclodextrin-based polymers for therapeutics delivery
06/27/2012CN102516405A Preparation method of chitosan oligosaccharide composite nanoparticles
06/27/2012CN102516404A Preparation method of rosuvastatin-dextran ester
06/27/2012CN102516399A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
06/27/2012CN102516397A Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine
06/27/2012CN102516395A Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
06/27/2012CN102516393A Insulin mimetic peptide fusion protein, mutant and applications thereof
06/27/2012CN102516392A Cancer-targeted super antigen fusion protein, and preparation method and application thereof
06/27/2012CN102516391A Neuropilin-1 ligand polypeptide-polyethylene glycol-phospholipid composite, its active targeting liposome vector system and preparation method thereof
06/27/2012CN102516388A Anthropogenic LMP1 (latent membrane protein1) extracellular regional antibody for nasopharyngeal carcinoma and application thereof
06/27/2012CN102516386A Il-21 derivatives
06/27/2012CN102516385A Nerve growth factor-paclitaxel conjugate, manufacturing method and uses thereof
06/27/2012CN102516361A NRP-1 ligand polypeptide-polyethylene glycol-phosphatide compound, active targeting liposome drug delivery system mediated thereby and preparation method thereof
06/27/2012CN102516321A Medicinal lactose, preparation method thereof, and purpose thereof
06/27/2012CN102516251A Medicines for targeted diagnosis and photosensitive therapy for cancer and application for same
06/27/2012CN102512692A Tumor targeting embolization therapeutic composition and preparation method thereof
06/27/2012CN102512691A Telmisartan composition and application thereof
06/27/2012CN102512690A Oleanolic acid-3-0-beta-D-glucuronopyranoside clathrate and preparation method as well as application thereof
06/27/2012CN102512689A Carrier composition for nucleic acid transport
06/27/2012CN102512688A Nilestriol-beta-cyclodextrin inclusion compound and preparation method thereof
06/27/2012CN102512687A PH-response anti-cancer medicinal preparation and preparation method thereof
06/27/2012CN102512686A Vaccine protectant, hydrophobia vaccine and preparation method thereof
06/27/2012CN102512685A Vaccine protection agent, and combined measles and Japanese encephalitis vaccine and preparation method thereof
06/27/2012CN102512684A Sustained release premixing agent
06/27/2012CN102512683A Polymer gene medicine carrier, preparation method thereof and use thereof for preparing antitumor medicine
06/27/2012CN102512674A Fish broad-spectrum vibrio subunit vaccine and preparation method
06/27/2012CN102512668A Lyophilized powder of adenosine disodium triphosphate, coenzyme A and insulin for injection and preparation method thereof
06/27/2012CN102512667A Lipid composition of insulin, preparation method thereof, and preparation thereof
06/27/2012CN102512659A Medicinal composition containing echinocandin antifungal agent and its preparing method and its use
06/27/2012CN102512658A Non-aqueous polar aprotic peptide formulations
06/27/2012CN102512657A Pentagastrin liquid injection and preparation method thereof
06/27/2012CN102512656A Quinapril hydrochloride medicinal composition
06/27/2012CN102512628A Antibacterial antiviral composition
06/27/2012CN102512577A Cough-relieving sea-buckthorn electuary
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 1712